These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 12548145)
1. Plasma gabapentin concentrations in children with epilepsy: influence of age, relationship with dosage, and preliminary observations on correlation with clinical response. Gatti G; Ferrari AR; Guerrini R; Bonanni P; Bonomi I; Perucca E Ther Drug Monit; 2003 Feb; 25(1):54-60. PubMed ID: 12548145 [TBL] [Abstract][Full Text] [Related]
2. Association between patient age and gabapentin serum concentration-to-dose ratio: a preliminary multivariate analysis. Armijo JA; Pena MA; Adín J; Vega-Gil N Ther Drug Monit; 2004 Dec; 26(6):633-7. PubMed ID: 15570187 [TBL] [Abstract][Full Text] [Related]
3. High dose gabapentin in refractory partial epilepsy: clinical observations in 50 patients. Wilson EA; Sills GJ; Forrest G; Brodie MJ Epilepsy Res; 1998 Jan; 29(2):161-6. PubMed ID: 9477149 [TBL] [Abstract][Full Text] [Related]
4. Conversion to high dose gabapentin monotherapy in patients with medically refractory partial epilepsy. Beydoun A; Fakhoury T; Nasreddine W; Abou-Khalil B Epilepsia; 1998 Feb; 39(2):188-93. PubMed ID: 9577999 [TBL] [Abstract][Full Text] [Related]
5. Effects of age and gender on single-dose pharmacokinetics of gabapentin. Boyd RA; Türck D; Abel RB; Sedman AJ; Bockbrader HN Epilepsia; 1999 Apr; 40(4):474-9. PubMed ID: 10219274 [TBL] [Abstract][Full Text] [Related]
6. Serum concentrations and effects of gabapentin and vigabatrin: observations from a dose titration study. Lindberger M; Luhr O; Johannessen SI; Larsson S; Tomson T Ther Drug Monit; 2003 Aug; 25(4):457-62. PubMed ID: 12883229 [TBL] [Abstract][Full Text] [Related]
7. Influence of dosage, age, and co-medication on plasma topiramate concentrations in children and adults with severe epilepsy and preliminary observations on correlations with clinical response. Ferrari AR; Guerrini R; Gatti G; Alessandrì MG; Bonanni P; Perucca E Ther Drug Monit; 2003 Dec; 25(6):700-8. PubMed ID: 14639056 [TBL] [Abstract][Full Text] [Related]
8. Gabapentin and cognition: a double blind, dose ranging, placebo controlled study in refractory epilepsy. Leach JP; Girvan J; Paul A; Brodie MJ J Neurol Neurosurg Psychiatry; 1997 Apr; 62(4):372-6. PubMed ID: 9120451 [TBL] [Abstract][Full Text] [Related]
10. Lack of interaction of gabapentin with carbamazepine or valproate. Radulovic LL; Wilder BJ; Leppik IE; Bockbrader HN; Chang T; Posvar EL; Sedman AJ; Uthman BM; Erdman GR Epilepsia; 1994; 35(1):155-61. PubMed ID: 8112239 [TBL] [Abstract][Full Text] [Related]
11. The absorption of gabapentin following high dose escalation. Berry DJ; Beran RG; Plunkeft MJ; Clarke LA; Hung WT Seizure; 2003 Jan; 12(1):28-36. PubMed ID: 12495646 [TBL] [Abstract][Full Text] [Related]
12. Gabapentin as add-on therapy in children with refractory partial seizures: a 12-week, multicentre, double-blind, placebo-controlled study. Gabapentin Paediatric Study Group. Appleton R; Fichtner K; LaMoreaux L; Alexander J; Halsall G; Murray G; Garofalo E Epilepsia; 1999 Aug; 40(8):1147-54. PubMed ID: 10448830 [TBL] [Abstract][Full Text] [Related]
13. Determination of gabapentin-lactam in serum of patients under gabapentin therapy. Knörle R; Feuerstein TJ; Schulze-Bonhage A Arzneimittelforschung; 2004; 54(3):139-42. PubMed ID: 15112859 [TBL] [Abstract][Full Text] [Related]
14. Gabapentin bioavailability: effect of dose and frequency of administration in adult patients with epilepsy. Gidal BE; DeCerce J; Bockbrader HN; Gonzalez J; Kruger S; Pitterle ME; Rutecki P; Ramsay RE Epilepsy Res; 1998 Jul; 31(2):91-9. PubMed ID: 9714500 [TBL] [Abstract][Full Text] [Related]
15. Oral gabapentin disposition in patients with epilepsy after a high-protein meal. Benetello P; Furlanut M; Fortunato M; Baraldo M; Pea F; Tognon A; Testa G Epilepsia; 1997 Oct; 38(10):1140-2. PubMed ID: 9579961 [TBL] [Abstract][Full Text] [Related]
16. Gabapentin in childhood epilepsy: a prospective evaluation of efficacy and safety. Korn-Merker E; Borusiak P; Boenigk HE Epilepsy Res; 2000 Jan; 38(1):27-32. PubMed ID: 10604603 [TBL] [Abstract][Full Text] [Related]
17. Double-blind study of Gabapentin in the treatment of partial seizures. Sivenius J; Kälviäinen R; Ylinen A; Riekkinen P Epilepsia; 1991; 32(4):539-42. PubMed ID: 1907907 [TBL] [Abstract][Full Text] [Related]
18. AUStralian study of titration to effect profile of safety (AUS-STEPS): high-dose gabapentin (neurontin) in partial seizures. Beran R; Berkovic S; Black A; Danta G; Dunne J; Frasca J; Grainger K; Kilpatrick C; McKenzie R; McLaughlin D; Schapel G; Somerville E Epilepsia; 2001 Oct; 42(10):1335-9. PubMed ID: 11737169 [TBL] [Abstract][Full Text] [Related]
19. Gabapentin add-on treatment: how many patients become seizure-free? An open-label multicenter study. Mayer T; Schütte W; Wolf P; Elger CE Acta Neurol Scand; 1999 Jan; 99(1):1-7. PubMed ID: 9925232 [TBL] [Abstract][Full Text] [Related]
20. Failure of absorption of gabapentin after rectal administration. Kriel RL; Birnbaum AK; Cloyd JC; Ricker BJ; Jones Saete C; Caruso KJ Epilepsia; 1997 Nov; 38(11):1242-4. PubMed ID: 9579927 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]